
[Federal Register Volume 76, Number 175 (Friday, September 9, 2011)]
[Notices]
[Page 55928]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-23101]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0002]


Food and Drug Administration Health Professional Organizations 
Conference

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public conference.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a conference 
for representatives of Health Professional Organizations. Dr. Margaret 
Hamburg, Commissioner of the Food and Drugs, and Dr. Janet Woodcock, 
Director of FDA's Center for Drug Evaluation and Research have been 
invited to speak about their visions of the relationship between the 
Agency and the health professional community. Other topics on the 
agenda include Risk Evaluation and Mitigation Strategies and the 
Unapproved Drugs Initiative.
    Date and Time: The conference will be held on October 31, 2011, 
from 8 a.m. to 1:30 p.m.
    Location: The conference will be held at the FDA White Oak Campus, 
10903 New Hampshire Ave., Building 31 Conference Center, the Great Room 
(rm. 1503), Silver Spring, MD 20993-0002.
    Contact Person: For further information contact Janelle Derbis, 
Office of Special Health Issues, 10903 New Hampshire Ave., Silver 
Spring, MD 20993, 312-596-6516, Fax: 312-886-1682, 
Janelle.Derbis@fda.hhs.gov.
    Registration: Register at http://www.cvent.com/d/fcq7vv/4W by 
October 7, 2011. Please include the name and title of the person 
attending, the name of the organization, address, and telephone number. 
There is no registration fee for this conference. Early registration is 
suggested because space is limited. We request that organizations limit 
the number of representatives to two. For further registration 
information, call 1-866-318-4357.

SUPPLEMENTARY INFORMATION: The aim of the conference is to further the 
public health mission of the FDA through training, collaboration, and 
structured discussion between health professional organizations and FDA 
staff. The Office of Special Health Issues serves as a liaison between 
the FDA Centers and the public on matters that involve medical product 
safety and also acts as the public's link to information about the 
medical product approval process.
    The topics of discussion for this conference will include three 
separate panels that will highlight examples where FDA and health 
professional organizations collaborate to further public health. The 
goal of the panel presentations is to exchange ideas, highlight the 
value of FDA and health professional organizations working together, 
and encourage collaboration to promote public health. A list of 
concurrent breakout session topics is included in the agenda to 
facilitate informal discussion on how FDA and health professional 
organizations can collaborate more effectively. Please indicate during 
your registration the topics of greatest interest to you for the 
breakout session.
    If you need special accommodations due to a disability, please 
contact Janelle Derbis at least 7 days in advance.

    Dated: September 6, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-23101 Filed 9-8-11; 8:45 am]
BILLING CODE 4160-01-P


